HTL Biotechnology, market leader in biopolymers, acquires the Modern Meadow's human recombinant collagen platform for beauty and biomedical applications
Published on 08/07/2025 at 18:08 | prnewswire.co.uk
– 07 61 45 26 85
Olivier Clement – oclement@apcoworldwide.com – 07 64 47 24 07
Agence APCO : Nina Pereira – npereira@apcoworldwide.com – 06 80 20 23 02
Olivier Clement – oclement@apcoworldwide.com – 07 64 47 24 07
Agence APCO : Nina Pereira – npereira@apcoworldwide.com – 06 80 20 23 02
Logo - https://mma.prnewswire.com/media/2404503/HTL_Biotechnology_Logo.jpg
View original content:
en | boerse | 67934489 |
